The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia

<p>Abstract</p> <p>Elevated low-density lipoprotein (LDL)-cholesterol is associated with a significantly increased risk of coronary heart disease. Ezetimibe is the first member of a new class of selective cholesterol absorption inhibitors. It impairs the intestinal reabsorption of...

Full description

Bibliographic Details
Main Authors: Suleiman Ehab S, Choueiri Nabil E, Al-Shaer Moutasim H
Format: Article
Language:English
Published: BMC 2004-10-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://www.lipidworld.com/content/3/1/22